Viemed Healthcare (VMD)
Provides home ventilation, sleep therapy, and HME support for U.S. patients.
$8.84
vs last close−0.12 (−1.35%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 49 | 51 | 51 | 55 | 58 | 61 | 59 | 63 | 72 | 76 | 75 | 78 |
| Cost of revenue | 19 | 19 | 21 | 22 | 24 | 25 | 26 | 27 | 31 | 32 | 33 | 33 |
| Gross profit | 31 | 32 | 30 | 33 | 34 | 36 | 33 | 36 | 41 | 44 | 42 | 45 |
| 26 | 27 | 28 | 29 | 29 | 30 | 29 | 32 | 35 | 35 | 38 | 40 | |
| Research & development | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 25 | 25 | 26 | 28 | 28 | 30 | 31 | 31 | 34 | 35 | 35 | 39 | |
| General & administrative | 25 | 25 | 26 | 28 | 28 | 30 | 31 | 31 | 34 | 35 | 0 | 0 |
| Other expenses | 1 | 1 | 1 | 0 | 0 | −1 | −2 | 0 | 0 | 0 | 2 | 0 |
| Operating income | 4 | 5 | 2 | 4 | 6 | 6 | 4 | 5 | 6 | 9 | 5 | 5 |
| 0 | 0 | 0 | −1 | 0 | 0 | 0 | 0 | −1 | −1 | −1 | −1 | |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 1 | 0 | 1 | 2 | −1 | 0 | 0 | 0 | 0 |
| Income before tax | 4 | 5 | 2 | 2 | 5 | 6 | 4 | 5 | 5 | 8 | 4 | 4 |
| Income tax expense | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 1 | 1 |
| Net income from continuing operations | 3 | 3 | 2 | 1 | 4 | 4 | 3 | 3 | 4 | 6 | 3 | 3 |
| Other adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 3 | 3 | 2 | 1 | 4 | 4 | 3 | 3 | 4 | 6 | 3 | 3 |
| EPS, basic | $0.08 | $0.09 | $0.04 | $0.04 | $0.10 | $0.11 | $0.07 | $0.08 | $0.09 | $0.15 | $0.07 | $0.07 |
| EPS, diluted | $0.07 | $0.09 | $0.04 | $0.04 | $0.10 | $0.10 | $0.06 | $0.08 | $0.09 | $0.14 | $0.06 | $0.07 |
| Weighted average shares, basic | 38 | 38 | 39 | 39 | 39 | 39 | 39 | 40 | 39 | 38 | 38 | 38 |
| Weighted average shares, diluted | 40 | 40 | 41 | 41 | 41 | 42 | 42 | 41 | 40 | 40 | 40 | 41 |
| EBITDA | 10 | 11 | 9 | 9 | 12 | 12 | 8 | 12 | 13 | 16 | 12 | 13 |
| Depreciation & amortization | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 8 | 8 | 8 | 8 |
| EBIT | 4 | 5 | 2 | 3 | 6 | 5 | 2 | 5 | 6 | 8 | 4 | 5 |